| 201 | Workday Inc | 5 992 | 778,5 k $ | |
| 202 | Charter Communications, Inc. | 3 562 | 769 k $ | |
| 203 | Kraft Heinz Co/The | 33 299 | 748,9 k $ | |
| 204 | Philip Morris International Inc. | 4 433 | 738,3 k $ | |
| 205 | RTX Corp | 3 818 | 736,5 k $ | |
| 206 | Verisk Analytics Inc | 3 880 | 736,2 k $ | |
| 207 | Goldman Sachs Group Inc/The | 854 | 722,5 k $ | |
| 208 | Oracle Corp | 4 909 | 722,2 k $ | |
| 209 | Wells Fargo & Co | 8 938 | 711,6 k $ | |
| 210 | Ligand Pharmaceuticals Inc | 3 539 | 706,6 k $ | |
| 211 | Spyre Therapeutics Inc | 13 938 | 703 k $ | |
| 212 | JOYY Inc | 12 000 | 700,7 k $ | |
| 213 | UnitedHealth Group Inc | 2 579 | 697,9 k $ | |
| 214 | Amneal Pharmaceuticals Inc | 55 834 | 694 k $ | |
| 215 | Indivior Pharmaceuticals Inc | 22 194 | 676,5 k $ | |
| 216 | GE Vernova Inc | 773 | 675,1 k $ | |
| 217 | Crinetics Pharmaceuticals Inc | 18 581 | 674,9 k $ | |
| 218 | ACADIA Pharmaceuticals Inc | 30 256 | 673,5 k $ | |
| 219 | Structure Therapeutics Inc | 13 824 | 666,3 k $ | |
| 220 | Select Sector Spdr Trust | 6 030 | 657,1 k $ | |
| 221 | International Business Machines Corp. | 2 662 | 645,2 k $ | |
| 222 | STMicroelectronics NV | 18 000 | 621,9 k $ | |
| 223 | Verizon Communications Inc | 12 006 | 602,7 k $ | |
| 224 | ARM Holdings PLC | 3 928 | 594,2 k $ | |
| 225 | Travere Therapeutics Inc | 19 825 | 589 k $ | |
| 226 | Morgan Stanley | 3 381 | 556,4 k $ | |
| 227 | Vnet Group Inc | 65 000 | 545,4 k $ | |
| 228 | Disc Medicine Inc | 8 372 | 535,3 k $ | |
| 229 | Tarsus Pharmaceuticals Inc | 7 552 | 529,8 k $ | |
| 230 | Dyne Therapeutics Inc | 29 219 | 529,7 k $ | |
| 231 | Supernus Pharmaceuticals Inc | 10 175 | 525,9 k $ | |
| 232 | Ideaya Biosciences Inc | 15 583 | 519,2 k $ | |
| 233 | Arcutis Biotherapeutics Inc | 22 011 | 518,6 k $ | |
| 234 | Twist Bioscience Corp | 10 880 | 517 k $ | |
| 235 | Rambus Inc | 6 000 | 516,2 k $ | |
| 236 | Sarepta Therapeutics Inc | 23 595 | 513,4 k $ | |
| 237 | EyePoint Inc | 39 691 | 511,6 k $ | |
| 238 | Vera Therapeutics Inc | 12 663 | 509,4 k $ | |
| 239 | Tango Therapeutics Inc | 23 900 | 500 k $ | |
| 240 | Alumis Inc | 22 436 | 494,3 k $ | |
| 241 | Stoke Therapeutics Inc | 15 136 | 492,8 k $ | |
| 242 | Rubrik Inc | 10 000 | 489,7 k $ | |
| 243 | CoStar Group Inc | 11 809 | 476,4 k $ | |
| 244 | Natera Inc | 2 330 | 466 k $ | |
| 245 | Veracyte Inc | 14 101 | 454,2 k $ | |
| 246 | NIO Inc | 75 000 | 452,3 k $ | |
| 247 | 10X Genomics Inc | 20 882 | 443,3 k $ | |
| 248 | Beam Therapeutics Inc | 18 075 | 430,7 k $ | |
| 249 | Intellia Therapeutics Inc | 33 464 | 429 k $ | |
| 250 | BioCryst Pharmaceuticals Inc | 44 507 | 423,7 k $ | |
| 251 | GRAIL Inc | 8 168 | 422,1 k $ | |
| 252 | Oruka Therapeutics Inc | 8 591 | 421,4 k $ | |
| 253 | Kodiak Sciences Inc | 10 834 | 413 k $ | |
| 254 | Enliven Therapeutics Inc | 10 532 | 412,9 k $ | |
| 255 | Agilent Technologies Inc | 3 600 | 411,2 k $ | |
| 256 | WeRide Inc | 50 000 | 404,5 k $ | |
| 257 | ON Semiconductor Corp | 6 500 | 402,5 k $ | |
| 258 | Adaptive Biotechnologies Corp | 28 925 | 401,5 k $ | |
| 259 | Corvus Pharmaceuticals Inc | 27 155 | 397,3 k $ | |
| 260 | Day One Biopharmaceuticals Inc | 18 331 | 393 k $ | |
| 261 | Trevi Therapeutics Inc | 32 755 | 390,8 k $ | |
| 262 | Hesai Group | 20 000 | 382,4 k $ | |
| 263 | ADMA Biologics Inc | 42 263 | 380,8 k $ | |
| 264 | Mineralys Therapeutics Inc | 14 044 | 380,5 k $ | |
| 265 | Rapport Therapeutics Inc | 12 058 | 377,3 k $ | |
| 266 | Repligen Corp | 3 200 | 377 k $ | |
| 267 | Design Therapeutics Inc | 35 109 | 373,6 k $ | |
| 268 | Elevance Health Inc | 1 250 | 365,9 k $ | |
| 269 | Syndax Pharmaceuticals Inc | 15 652 | 365,6 k $ | |
| 270 | Tyra Biosciences Inc | 9 471 | 362,7 k $ | |
| 271 | Ultragenyx Pharmaceutical Inc | 17 148 | 359,3 k $ | |
| 272 | Maze Therapeutics Inc | 11 995 | 358,1 k $ | |
| 273 | Agios Pharmaceuticals Inc | 10 398 | 351,8 k $ | |
| 274 | Zeta Global Holdings Corp | 22 000 | 350,2 k $ | |
| 275 | AnaptysBio Inc | 6 164 | 341,9 k $ | |
| 276 | Insulet Corp | 1 600 | 335,7 k $ | |
| 277 | Zymeworks Inc | 13 280 | 332,5 k $ | |
| 278 | Ocular Therapeutix Inc | 38 631 | 327,2 k $ | |
| 279 | Atlassian Corp | 4 771 | 325,6 k $ | |
| 280 | Immunocore Holdings PLC | 10 783 | 325,1 k $ | |
| 281 | Annexon Inc | 57 683 | 319,6 k $ | |
| 282 | Sionna Therapeutics Inc | 7 920 | 317,5 k $ | |
| 283 | Relay Therapeutics Inc | 31 716 | 315,6 k $ | |
| 284 | Quest Diagnostics Inc | 1 600 | 313,6 k $ | |
| 285 | Hilton Worldwide Holdings Inc | 1 021 | 310,5 k $ | |
| 286 | Genmab A/S | 11 424 | 306,5 k $ | |
| 287 | Innoviva Inc | 13 145 | 306,3 k $ | |
| 288 | ANI Pharmaceuticals Inc | 3 978 | 305,9 k $ | |
| 289 | Novo Nordisk A/S | 8 100 | 305,1 k $ | |
| 290 | Snowflake Inc | 2 000 | 301,6 k $ | |
| 291 | Astera Labs Inc | 2 700 | 295,9 k $ | |
| 292 | Vericel Corp | 9 008 | 289,8 k $ | |
| 293 | Nektar Therapeutics | 4 000 | 287,8 k $ | |
| 294 | Harmony Biosciences Holdings Inc | 10 264 | 287,5 k $ | |
| 295 | Septerna Inc | 11 946 | 287,1 k $ | |
| 296 | Recursion Pharmaceuticals Inc | 92 624 | 284,4 k $ | |
| 297 | Nurix Therapeutics Inc | 18 250 | 282,9 k $ | |
| 298 | IQVIA Holdings Inc | 1 600 | 272,9 k $ | |
| 299 | LEGEND BIOTECH CORP | 14 978 | 271 k $ | |
| 300 | Amylyx Pharmaceuticals Inc | 19 488 | 270,9 k $ | |